Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Tackling COVID-19 Pandemic through Research in Latin America and the Caribbean: A Bibliometric Analysis

Version 1 : Received: 12 November 2020 / Approved: 13 November 2020 / Online: 13 November 2020 (07:09:52 CET)

How to cite: Espinosa, I.; Cuenca, V.; Eissa-Garcés, A.; Sisa, I. Tackling COVID-19 Pandemic through Research in Latin America and the Caribbean: A Bibliometric Analysis. Preprints 2020, 2020110362. https://doi.org/10.20944/preprints202011.0362.v1 Espinosa, I.; Cuenca, V.; Eissa-Garcés, A.; Sisa, I. Tackling COVID-19 Pandemic through Research in Latin America and the Caribbean: A Bibliometric Analysis. Preprints 2020, 2020110362. https://doi.org/10.20944/preprints202011.0362.v1

Abstract

Latin America and the Caribbean (LAC) is one of the worst-hit regions globally by COVID-19 pandemic. Yet, scarce literature exists that examines the research strategy of LAC in facing COVID-19. The present study aims to quantify and assess the production of COVID-19 publications in thirty-two countries in LAC during the first half of 2020. A Scopus/PubMed/LILACS search was performed to retrieve research articles related to COVID-19 published from January 1 to July 31, 2020. Subgroup analysis including only original publications was used to better ascertain the contribution of LAC countries, and standardization measures were applied to comparisons of country-specific contributions. We identified 1291 publications across the region. Overall, most articles in the region were non-original (81.6%), and the most productive countries were Brazil (43.9%), Mexico (9.14%), and Colombia (7.98%). This trend shifted to Chile after the standardization. Among original studies, the most common study design was cross-sectional (25.8%). LAC countries generate articles primarily pertaining to diagnosis and treatment (27.4%). In the subgroup analysis, however, epidemiology and surveillance was the most prevalent research focus (24.1%). LAC countries should perform more research with a higher level of evidence to inform health policy making to ease the burden of COVID-19 in the region.

Keywords

Health research policy; National health research system; COVID-19; Biomedical Research; Latin America and Caribbean

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.